Drugplain

ADYNOVATE

Antihemophilic Factor (Recombinant) PEGylated · KIT · Takeda Pharmaceuticals Amercia, Inc.

No Recall History
Plain English

Adynovate is a blood clotting medication used to treat and prevent bleeding in people with hemophilia A. It is a man-made version of a protein that helps blood clot normally.

Key Facts

Brand Name
ADYNOVATE
Generic Name
Antihemophilic Factor (Recombinant) PEGylated
NDC Code (Product)
0944-4627
Manufacturer
Takeda Pharmaceuticals Amercia, Inc.
Dosage Form
KIT
Marketing Status
Application #
BLA125566
Marketing Start
11/13/2015

Recall History

No Recall History

Frequently Asked Questions

What is ADYNOVATE used for?

Adynovate is a blood clotting medication used to treat and prevent bleeding in people with hemophilia A. It is a man-made version of a protein that helps blood clot normally.

Is ADYNOVATE a controlled substance?

ADYNOVATE is not classified as a controlled substance by the DEA.

What is the generic name for ADYNOVATE?

The generic name for ADYNOVATE is Antihemophilic Factor (Recombinant) PEGylated. There are 5 other brand versions of Antihemophilic Factor (Recombinant) PEGylated.

What is the NDC code for ADYNOVATE ?

The NDC (National Drug Code) for ADYNOVATE is 0944-4627, listed by Takeda Pharmaceuticals Amercia, Inc..

Product NDC

0944-4627

Package NDC

0944-4627-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)